GPR 17 Agonists and Screening Assay

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

13775433

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is related to a method of determining a test compound's ability to modify the biological activity of a GPR17. Said method comprises, among others, the step of contacting the test compound with a GPR17, or a functional GPR17 fragment in the presence of a suitable amount of a GPR17 agonist of formula I.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN53113 BONN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Akkari, Rhalid Pantin, FR 17 195
Baqi, Younis Bonn, DE 4 5
Hennen, Stephanie Saarburg, DE 11 7
Kostenis, Evi Bonn, DE 23 104
Muller, Christa E Bonn, DE 5 1
Peters, Lucas Bad Honnef, DE 3 1
Ritter, Kirsten Jena, DE 3 1
Spinrath, Andreas Munchen, DE 3 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation